[HTML][HTML] Epidemiology of non-alcoholic and alcoholic fatty liver diseases

S Mitra, A De, A Chowdhury - Translational gastroenterology and …, 2020 - ncbi.nlm.nih.gov
Liver diseases are fast emerging as global health priorities. Fatty liver is described in the
setting of non-alcoholic fatty liver disease (NAFLD) as well as alcoholic liver disease (ALD) …

Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021

AF Peery, SD Crockett, CC Murphy, ET Jensen, HP Kim… - Gastroenterology, 2022 - Elsevier
Background & Aims Gastrointestinal diseases account for considerable health care use and
expenditures. We estimated the annual burden, costs, and research funding associated with …

[PDF][PDF] Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases

DW Crabb, GY Im, G Szabo, JL Mellinger… - Hepatology, 2020 - Wiley Online Library
Alcohol-associated liver disease (ALD) represents a spectrum of liver injury resulting from
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …

Diagnosis and management of hepatic encephalopathy: The French recommendations

D Thabut, C Bouzbib, L Meunier, M Haas… - Liver …, 2023 - Wiley Online Library
Hepatic encephalopathy (HE) is a frequent and severe complication of liver disease with
poor patient outcomes. However, it is a poorly understood complication, with no consensus …

Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis

PS Kamath, VM Karpyak, B Davis, V Desai… - Clinical …, 2020 - Elsevier
Background & Aims Patients admitted to the hospital for alcoholic hepatitis (AH) are at
increased risk of readmission and death. We aimed to identify factors associated with …

Coronary reactivity assessment is associated with lower health care–associated costs in patients presenting with angina and nonobstructive coronary artery disease

A Ahmad, MT Corban, JP Moriarty… - Circulation …, 2023 - Am Heart Assoc
BACKGROUND: The financial burden linked to the diagnosis and treatment of patients with
chest pain on the health care system is considerable. Angina and nonobstructive coronary …

[HTML][HTML] Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database

SK Garg, H Goyal, I Obaitan, PA Shah… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Cirrhosis is associated with substantial inpatient morbidity and mortality. This
study aimed to determine the trends in 30-day hospital readmission rates among patients …

Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians

EE Powell, R Skoien, T Rahman, PJ Clark… - …, 2019 - thelancet.com
Background Limited information is available about hospitalization rates for cirrhosis in
Australia. Methods Using information on all hospital episodes of care for patients admitted to …

Systematic review of the economic burden of overt hepatic encephalopathy and pharmacoeconomic impact of rifaximin

G Neff, WZ III - Pharmacoeconomics, 2018 - Springer
Background Hepatic encephalopathy (HE), a common neurologic complication in cirrhosis,
is associated with substantial disease and economic burden. Rifaximin is a non-systemic …

Increasing prevalence of cirrhosis among insured adults in the United States, 2012–2018

DP Ladner, M Gmeiner, BJ Hasjim, N Mazumder… - PloS one, 2024 - journals.plos.org
Background Liver cirrhosis is a chronic disease that is known as a “silent killer” and its true
prevalence is difficult to describe. It is imperative to accurately characterize the prevalence of …